The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Panteleev V.I.

A.V. Vishnevsky Institute of Surgery, Moscow, Russia

Gorin D.S.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Kaldarov A.R.

Institut khirurgii im. A.V. Vishnevskogo Minzdrava Rossii, Moskva

Kriger A.G.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Intraductal papillary mucinous neoplasm of pancreas

Authors:

Panteleev V.I., Gorin D.S., Kaldarov A.R., Kriger A.G.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2019;(11): 81‑87

DOI: 10.17116/hirurgia201911181

Read: 34296 times

Download PDF (RU)
Contact the author
Table of contents

INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF PANCREAS
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF PANCREAS

To cite this article:

Panteleev VI, Gorin DS, Kaldarov AR, Kriger AG. Intraductal papillary mucinous neoplasm of pancreas. Pirogov Russian Journal of Surgery. 2019;(11):81‑87. (In Russ.)
https://doi.org/10.17116/hirurgia201911181

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Pancreaticoduodenectomy combined with multivisceral rese­ctions. Piro­gov Russian Journal of Surgery. 2024;(11):77-83
Cystic-solid transformation of the pancreas and kidneys due to von Hippel-Lindau disease. Piro­gov Russian Journal of Surgery. 2025;(10):118-125
Portal homo­graft in pancreatic head cancer surgery: first expe­rience. P.A. Herzen Journal of Onco­logy. 2025;(1):42-47
Use of HIFU therapy in combination with mono­chemotherapy in a patient with loca­lly adva­nced adenogenic pancreatic cancer and impaired functional status. P.A. Herzen Journal of Onco­logy. 2025;(3):83-88
Infu­sion therapy and acinar component of the pancreas as predictors of pancreatic fistula in pancreatoduodenectomy. Russian Journal of Anesthesiology and Reanimatology. 2025;(5):58-65
Abstract:

Intraductal papillary mucinous neoplasm (IPMN) is the most common cystic pancreatic tumor. There are 3 ductal types of this tumor depending on localization. Several histological subtypes determine clinical course and prognosis. The problems of diagnosis, surgical treatment and follow-up are reviewed in several guidelines. Literature review devoted to pancreatic IPMN is presented in the article, the latest guidelines are compared.

Keywords:

intraductal papillary mucinous neoplasm
cystic tumor
pancreas
pancreatic cancer

Authors:

Panteleev V.I.

A.V. Vishnevsky Institute of Surgery, Moscow, Russia

Gorin D.S.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Kaldarov A.R.

Institut khirurgii im. A.V. Vishnevskogo Minzdrava Rossii, Moskva

Kriger A.G.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Close metadata

References:

  1. Gorin DS, Smirnov AV. Intraductal papillary mucinous tumor of the pancreas. Consilium Medicum. Surgery (Suppl.). 2016;2:18-23. (In Russ.) http://con-med.ru/magazines/surgery/surgery-02-2016/vnutriprotokovaya_papillyarno_mutsinoznaya_opukhol_podzheludochnoy_zhelezy/
  2. Ohashi K, Tajiri H, Gondo M, Yokoyama Y, Maruyama M, Takekoshi T, Matsuura Y, Kasumi F, Takagi K, Kato Y: A case of cystadenocarcinoma of the pancreas forming biliopancreatic fistula. Prog Dig Endosc. 1980;17:261-264. https://ci.nii.ac.jp/naid/10007607131/
  3. Ohashi KMY, Maruyama M. Four cases of mucin producing cancer of the pancreas on specific findings of the papilla of Vater (in Japanese). Prog Dig Endosc. 1982;20:348-351. https://ci.nii.ac.jp/naid/10016168281/
  4. Tollefson MK, Libsch KD, Sarr MG, et al. Intraductal papillary mucinous neoplasm: did it exist prior to 1980? Pancreas. 26(3):e55-e58, APR 2003 https://www.ncbi.nlm.nih.gov/pubmed/12657965
  5. Werner J, Fritz S, Buchler MW. Intraductal papillary mucinous neoplasms of the pancreas–a surgical disease. Nat Rev Gastroenterol Hepatol. 2012;9:253-259. https://doi.org/10.1038/nrgastro.2012.31
  6. Kloppel G, Solcia E, Longnecker DS, et al. World Health Organization International. Histological typing of tumors of the exocrine pancreas. Berlin: Springer; 1996. http://www.who.int/iris/handle/10665/37470
  7. Longnecker DS, Adler G, Hruban RH, Kloppel G. WHO Classification of Tumors. Lyon, IARC Press, 2000.
  8. Tanaka M. Thirty Years of Experience with Intraductal Papillary Mucinous Neoplasm of the Pancreas: From Discovery to International Consensus. Digestion. 2014;90:265-272. https://doi.org/10.1159/000370111
  9. Aronsson L, Andersson R, Ansari D. Intraductal papillary mucinous neoplasm of the pancreas — epidemiology, risk factors, diagnosis, and management. Scand J Gastroenterol. 2017 Aug;52(8):803-815. https://doi.org/10.1080/00365521.2017.1318948
  10. Machado NO, Al Qadhi H, Al Wahibi K. Intraductal Papillary Mucinous Neoplasm of Pancreas. N Am J Med Sci. 2015 May;7(5):160-175. https://doi.org/10.4103/1947-2714.157477
  11. Kimura W, Nagai H, Kuroda A, Muto T, Esaki Y. Analysis of small cystic lesions of the pancreas. Int J Pancreatol. 1995 Dec;18(3):197-206. https://doi.org/10.1007/BF02784942
  12. Kosmahl M, Pauser U, Peters K, et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch. 2004 Aug;445(2):168-178. https://doi.org/10.1007/s00428-004-1043-z
  13. Yoon WJ, Lee JK, Lee KH, et al. Cystic neoplasms of the exocrine pancreas: an update of a nationwide survey in Korea. Pancreas. 2008 Oct;37(3):254-258. https://doi.org/10.1097/MPA.0b013e3181676ba4
  14. Capurso G, Boccia S, Salvia R, et al. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Am J Gastroenterol. 2013 Jun;108(6):1003-1009. https://doi.org/10.1038/ajg.2013.42
  15. Gaujoux S, Salenave S, Ronot M. Hepatobiliary and Pancreatic neoplasms in patients with McCune-Albright syndrome. J Clin Endocrinol Metab. 2014 Jan;99(1):E97-E101. https://doi.org/10.1210/jc.2013-1823
  16. Wu J, Matthaei H, Maitra A. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011 Jul 20;3(92):92ra66. https://doi.org/10.1126/scitranslmed.3002543
  17. Jeurnink SM, Vleggaar FP, Siersema PD. Overview of the clinical problem: facts and current issues of mucinous cystic neoplasms of the pancreas. Dig Liver Dis. 2008 Nov;40(11):837-846. https://doi.org/10.1016/j.dld.2008.03.018
  18. Hwang DW, Jang JY, Lee SE, et al. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbecks Arch Surg. 2012 Jan;397(1):93-102. https://doi.org/10.1007/s00423-010-0674-6
  19. Crippa S, Fernández-Del Castillo C, Salvia R, et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol. 2010 Feb;8(2):213-219. https://doi.org/10.1016/j.cgh.2009.10.001
  20. Marchegiani G, Mino-Kenudson M, Sahora K, et al. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection. Ann Surg. 2015 May;261(5):976-983. https://doi.org/10.1097/SLA.0000000000000813
  21. Kim YI, Shin SH, Song KB, et al. Branch duct intraductal papillary mucinous neoplasm of the pancreas: single-center experience with 324 patients who underwent surgical resection. Korean J Hepatobiliary Pancreat Surg. 2015 Aug;19(3):113-120. https://doi.org/10.14701/kjhbps.2015.19.3.113
  22. Mori Y, Ohtsuka T, Kono H, et al. Management strategy for multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2012 Oct;41(7):1008-1012. https://doi.org/10.1097/MPA.0b013e31824b22c6
  23. Tamura K, Ohtsuka T, Matsunaga T, et al. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis. Surgery. 2015 Feb;157(2):277-284. https://doi.org/10.1016/j.surg.2014.09.013
  24. He J, Cameron JL, Ahuja N, et al. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg. 2013 Apr;216(4):657-665;discussion 665-667. https://doi.org/10.1016/j.jamcollsurg.2012.12.026
  25. Rezaee N, Barbon C, Zaki A, et al. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. HPB (Oxford). 2016 Mar;18(3):236-246. https://doi.org/10.1016/j.hpb.2015.10.010
  26. Furukawa T, Klöppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005 Nov;447(5):794-799. https://doi.org/10.1007/s00428-005-0039-7
  27. Qi X, Zhao X, Su J, et al. Malignant transformation and overall survival of morphological subtypes of intraductal papillary mucinous neoplasms of the pancreas: A network metaanalysis. Eur J Intern Med. 2015 Oct;26(8):652-657. https://doi.org/10.1016/j.ejim.2015.07.016
  28. Koh YX, Zheng HL2, Chok AY, et al. Systematic review and meta-analysis of the spectrum and outcomes of different histologic subtypes of noninvasive and invasive intraductal papillary mucinous neoplasms. Surgery. 2015 Mar;157(3):496-509. https://doi.org/10.1016/j.surg.2014.08.098
  29. Mino-Kenudson M, Fernández-del Castillo C, Baba Y, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. 2011 Dec;60(12):1712-1720. https://doi.org/10.1136/gut.2010.232272
  30. Waters JA, Schnelldorfer T, Aguilar-Saavedra JR, et al. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage. J Am Coll Surg. 2011 Aug;213(2):275-283. https://doi.org/10.1016/j.jamcollsurg.2011.04.003
  31. Yamaguchi K, Tanaka M, Nakamura K, Yokohata K, et al. Pancreatic cyst as a sentinel of in situ carcinoma of the pancreas. Report of two cases. Int J Pancreatol. 1997 Dec;22(3):227-231. https://doi.org/10.1007/BF02788389
  32. Yamaguchi K, Ohuchida J, Ohtsuka T, et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology. 2002;2(5):484-490. https://doi.org/10.1159/000064716
  33. Uehara H, Nakaizumi A, Ishikawa O, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 2008 Nov;57(11):1561-1565. https://doi.org/10.1136/gut.2007.145631
  34. Ideno N, Ohtsuka T, Kono H, et al. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg. 2013 Jul;258(1):141-151. https://doi.org/10.1097/SLA.0b013e31828cd008
  35. Mouawad NJ, Leichtle SW, Kaoutzanis C, et al. Pain control with continuous infusion preperitoneal wound catheters versus continuous epidural analgesia in colon and rectal surgery: A randomized controlled trial. Am J Surg. 2018 Apr;215(4):570-576. https://doi.org/10.1016/j.amjsurg.2017.06.031
  36. Castellano-Megías VM, Andrés CI, López-Alonso G, et al. Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas. World J Gastrointest Oncol. 2014 Sep 15;6(9):311-324. https://doi.org/10.4251/wjgo.v6.i9.311
  37. Tanaka M, Fernández-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017 Sep-Oct;17(5):738-753. https://doi.org/10.1016/j.pan.2017.07.007
  38. Del Chiaro M, Besselink MG, Scholten L, et al. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018 May;67(5):789-804. https://doi.org/10.1136/gutjnl-2018-316027
  39. Takanami K, Hiraide T, Tsuda M, et al. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Ann Nucl Med. 2011 Aug;25(7):501-510. https://doi.org/10.1136/10.1007/s12149-011-0494-y
  40. Nakamura M, Miyasaka Y, Sadakari Y, et al. Comparison of guidelines for intraductal papillary mucinous neoplasm: What is the next step beyond the current guidelines? Ann Gastroenterol Surg. 2017 Jun 16;1(2): 90-98. https://doi.org/10.1002/ags3.12012
  41. Vege SS, Ziring B, Jain R, et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015 Apr;148(4):819-822;quize 12-13. https://doi.org/10.1053/j.gastro.2015.01.015
  42. Lekkerkerker SJ, Besselink MG, Busch OR et al. Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome. Gastrointest Endosc. 2017 May;85(5):1025-1031. https://doi.org/10.1016/j.gie.2016.09.027
  43. Singhi AD, Zeh HJ, Brand RE, et al. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data. Gastrointest Endosc. 2016 Jun;83(6):1107-1117.e2. https://doi.org/10.1016/j.gie.2015.12.009
  44. Crippa S, Pergolini I, Rubini C, et al. Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms. Surgery. 2016 Apr;159(4):1041-1049. https://doi.org/10.1016/j.surg.2015.11.003
  45. Caponi S, Vasile E, Funel N et al. Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms. Eur J Surg Oncol. 2013 Apr;39(4):396-403. https://doi.org/10.1016/j.ejso.2012.12.005
  46. Marchegiani G, Andrianello S, Dal Borgo C, et al. Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data. HPB (Oxford). 2018 Oct 23. pii: S1365-182X(18)34463-0. https://doi.org/1010.1016/j.hpb.2018.09.013
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.